Embolization

New Late Breaking Preliminary Data Demonstrate Balt’s Squid™ Liquid Embolic May Improve Outcomes in Patients with Chronic Subdural Hematomas

Retrieved on: 
Friday, February 9, 2024
Randomized controlled trial, Balts, Veterans' affairs, Embolization, FDA, Prevalence, STEM, Disability, Conference, University, SDH, Physician, MPH, United, MMA, IDE, Incidence, Epidural hematoma, Patient, Person, Stony Brook University Hospital, Ageing, Disease, Doctor of Philosophy, Death, Pharmaceutical industry

The preliminary data demonstrates that rates of complications thus far are low and embolizing the MMA for the treatment of Chronic Subdural Hematoma (cSDH) potentially improves the success rates of both surgical and non-surgical treatments.

Key Points: 
  • The preliminary data demonstrates that rates of complications thus far are low and embolizing the MMA for the treatment of Chronic Subdural Hematoma (cSDH) potentially improves the success rates of both surgical and non-surgical treatments.
  • Standard management included surgical drainage of the subdural hemorrhage for qualified patients and best medical management for patients who did not require surgery.
  • STEM, which completed enrollment last year, is the first prospective IDE trial investigating embolization of the MMA for the treatment of chronic Sub-Dural Hematoma (cSDH).
  • A Veterans Affairs (VA) study of cSDH found a prevalence rate of 79.4 per 100,000 persons.

Global Oncology Devices Research Report 2023: Enhanced Treatment Options Propels Growth - Analysis by Device Type (Ablation, Embolization), & Cancer Type (Breast, Uterine, Colon and Rectum, Prostate) - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 31, 2023
Health, Oncology, Medical Devices, Research report, Surgery, Value, Breast cancer, Radiation, Cancer, Ageing, Prostate, Ablation, USD, Incidence, Uterine cancer, Colon, Patient, Application, Prostate cancer, SCSI Peripheral Device Type, Protocol on Mines, Booby-Traps and Other Devices, PET/CT, Disease, Diagnosis, Mortality, Biopsy, Medical imaging, Speciality chemicals, Rectum, Embolization, Select, Breast

The Global Oncology Devices Market is expected to generate 217.00 billion by the end of 2029, up from USD 69.80 Billion in 2022.

Key Points: 
  • The Global Oncology Devices Market is expected to generate 217.00 billion by the end of 2029, up from USD 69.80 Billion in 2022.
  • During the forecast period, 2024-2029, the Global Oncology Devices market is expected to grow at a CAGR of 18.05%.
  • The oncology devices market is comprised of a vast assortment of medical devices used for the detection, treatment, and management of cancer.
  • PET/CT price in Select countries, In EUR
    Global Oncology Devices Market Segmentation: By Device Type
    Global Oncology Devices Market Size, By Ablation Devices, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Embolization devices, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Other Devices, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Segmentation: By Cancer Type
    Global Oncology Devices Market Size, By Breast cancer, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Uterine cancer, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Colon and rectum cancer, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Prostate cancer, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Other Cancer Types, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Segmentation: By Application
    Global Oncology Devices Market Size, By Chemotherapy, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Radiation, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Surgical, By Value, 2019H-2029F (USD Billion & CAGR)
    Global Oncology Devices Market Size, By Diagnosis, By Value, 2019H-2029F (USD Billion & CAGR)

Fluidx Unveils New Embolic for Neurovascular Use

Retrieved on: 
Tuesday, January 10, 2023
Skull, Embolization, Blood, Disability, Research, MMA, DMSO, Brain, Death, SALT, Dura mater, Polymerization, CSDH, Patient, Pathology, Embolus, Medical imaging, Pharmaceutical industry

SALT LAKE CITY, Jan. 10, 2023 /PRNewswire/ -- Fluidx Medical Technology, Inc., released information regarding the success of the IMPASS Embolic Device in in-vivo research related to middle meningeal artery (MMA) embolizations which can be used to treat chronic subdural hematomas (CSDH) on the surface of the brain.[i]

Key Points: 
  • "We've been listening to clinicians and they need better tools to treat CSDH," says Danny Smith, VP of R&D for Fluidx.
  • The IMPASS Embolic Device is part of the portfolio of embolics currently under development by Fluidx.
  • Similar to the GPX Embolic Device, the IMPASS Embolic Device uses core Fluidx embolic technology but is designed specifically for neurovascular uses.
  • [ii]
    The Fluidx embolic platform is expected to bring simple preparation and controllable material delivery to a range of applications.

New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models

Retrieved on: 
Wednesday, August 10, 2022
Multimedia, DMSO, Polymerization, Embolus, Metal, Neoplasm, Technology, Aneurysm, Embolization, Birth, Bleeding, TACE, GPX, DVM, University of Utah, University, SALT, Microparticle, Blood, Bed, Medical imaging, Medical device

SALT LAKE CITY, Aug. 10, 2022 /PRNewswire/ -- Fluidx Medical disclosed study results examining extent of vessel filling using the GPX Embolic Device compared to microspheres, a common treatment for many types of tumors. 

Key Points: 
  • "The ability to fill the smallest tumor feeding vessels and reach distal vessel beds is very important in effective treatment of hypervascular tumors and in other therapeutic embolic procedures."
  • The GPX Embolic Device was found to fill vessels more completely and penetrate deeper into smaller vessel beds than the smallest microspheres commonly used for tumor treatments.
  • About the GPX Embolic Device:
    The GPX Embolic Device is an innovative embolic designed for simple preparation and controllable material delivery.
  • The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time.

Worldwide Embolotherapy Industry to 2026 - Increasing Demand for Minimally Invasive Procedures is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 6, 2021
Surgery, Health, Other Health, Mortality, PG, Gastrointestinal bleeding, Hemorrhoid, Cook Group, Prostatic artery embolization, Patient, Embolization, Disease, Stryker Corporation, PMDA, Microparticle, Growth, Gel, Hepatocellular carcinoma, Boston Scientific, Johnson & Johnson, Transplant, History, Medtronic, Time, Bleeding, CE marking, Industry, Medical imaging

Minimally invasive procedures are considered to be safe, and they are associated with reduced morbidity and mortality.

Key Points: 
  • Minimally invasive procedures are considered to be safe, and they are associated with reduced morbidity and mortality.
  • Due to these reasons, there has been increased demand for minimally invasive procedures such as embolization.
  • Also, it has been observed that with technological advancements, there has been growth in the embolic agents and their usage.
  • Procedures such as prostate artery embolization, bariatric embolization, embolization of hemorrhoids and others have also gained importance over time.

Insights on the Microspheres Global Market to 2026 - by Type, Raw Material, Application and Region - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 9, 2021
Health, Biotechnology, Interventional radiology, Embolization, Surgery, Compound annual growth rate

The "Microspheres Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Microspheres Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global microspheres market reached a value of US$ 4.6 Billion in 2020.
  • Looking forward, the publisher expects the global microspheres market to grow at a CAGR of 8.50% during 2021-2026.
  • In the medical sector, microspheres are used for drug administration and embolization, along with testing and development of medical equipment.

Global Neurovascular Devices/Interventional Neurology Market (2021 to 2026) - Rise in Demand for Minimally Invasive Neurosurgical Procedures Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 8, 2021
Surgery, Health, Medical devices, Interventional radiology, Medicine, Medical specialties, Clinical medicine, Interventional Neuroradiology, Embolization, Angiography, Thrombectomy, Stent, Angioplasty

The neurovascular devices/ interventional neurology market size is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion by 2026, at a CAGR of 8.6%.

Key Points: 
  • The neurovascular devices/ interventional neurology market size is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion by 2026, at a CAGR of 8.6%.
  • On the basis of product, the neurovascular devices/interventional neurology market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neuro thrombectomy devices.
  • Based on end-user, the neurovascular devices/interventional neurology market has been segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories, and academic institutes.
  • North America accounted for the largest market share in the neurovascular devices/interventional neurology market in 2020.

Global Interventional Oncology Market (2021 to 2026) - Emerging Economies Offer High Growth Potential - ResearchAndMarkets.com

Retrieved on: 
Monday, May 31, 2021
Health, Oncology, Medical specialties, Medicine, Clinical medicine, Cancer, Interventional oncology, Oncology, Radiology, Embolization

The global interventional oncology market size is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2020, at a CAGR of 6.8%.

Key Points: 
  • The global interventional oncology market size is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2020, at a CAGR of 6.8%.
  • The embolization devices segment to witness the highest share in interventional oncology market, by product, during the forecast period.
  • In 2020, embolization devices accounted for a share of the interventional oncology market.
  • The interventional oncology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Insights on the Neurovascular Devices Global Market to 2029 - Increasing Ageing Population in the Developed Nations Will Drive Growth

Retrieved on: 
Tuesday, May 11, 2021
Medical specialties, Medicine, Health care, Interventional radiology, Vascular diseases, Embolization, Surgery, Aneurysm, Food and Drug Administration

Increasing demand for minimally invasive procedures, growing commonness of neurovascular disorders and stroke, rapid new product development and commercialization drive the overall neurovascular devices market growth.

Key Points: 
  • Increasing demand for minimally invasive procedures, growing commonness of neurovascular disorders and stroke, rapid new product development and commercialization drive the overall neurovascular devices market growth.
  • Availability of a wide range of neurovascular devices, mainly in the aneurysm coiling and embolization devices segment enable professionals to meet the active demand.
  • Furthermore, rapid commercialization of novel devices and strong pipeline candidates under the FDA scrutiny would further drive the U.S. and therefore North America market.
  • The high procedural costs along with the need for skilled professionals is restraining the overall market growth.

Worldwide Neurovascular Devices Industry to 2029 - Featuring Penumbra, Phenox and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 6, 2021
Medical devices, Health, Medical specialties, Interventional radiology, Medicine, Clinical medicine, Vascular diseases, Aneurysm, Gross pathology, Embolization, Stroke, Stent, Neurovascular bundle, Alexander L. Coon

Availability of a wide range of neurovascular devices, mainly in the aneurysm coiling and embolization devices segment enable professionals to meet the active demand.

Key Points: 
  • Availability of a wide range of neurovascular devices, mainly in the aneurysm coiling and embolization devices segment enable professionals to meet the active demand.
  • As per the Internet Stroke Center statistics, around 75% of strokes take place in the age group of 60-65.
  • For example, with the introduction of new flow diversion stent technique, the need to treat complex aneurysms with bypasses has fallen down.
  • However, lack of skilled neurologists in hospitals is limiting the growth of neurovascular devices market.\n'